Category: CNS/Neurology
Global CNS/Neurology
-
Deep Brain Stimulation Devices Market by Product (Dual-Channel, Single Channel), Application (Depression, Dystonia, Epilepsy), End-User - Global Forecast 2024-2030
... expected to reach USD 1.76 billion in 2024, at a CAGR 15.06% to reach USD 4.10 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Deep Brain Stimulation Devices ... Read More
-
Neurorehabilitation Devices Market by Products (Brain-Computer Interface, Neurorobotics, Noninvasive Stimulators), Therapy Area (Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis) - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 1.42 billion in 2024, at a CAGR 7.62% to reach USD 2.22 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Brain Imaging Modalities Market by Imaging Type (Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET)), Patient Type (Adults & Paediatrics, Infants), End User - Global Forecast 2024-2030
... size was estimated at USD 14.87 billion in 2023 and expected to reach USD 16.05 billion in 2024, at a CAGR 7.66% to reach USD 24.94 billion by 2030. Global Brain Imaging Modalities Market FPNV ... Read More
-
Central Nervous System Biomarkers Market by Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), Disease Indication (Alzheimer’s Disease, Multiple Sclerosis, Parkinson’s Disease), Application, End-User - Global Forecast 2024-2030
... estimated at USD 4.37 billion in 2023 and expected to reach USD 4.81 billion in 2024, at a CAGR 10.39% to reach USD 8.73 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Clinical Research Services Market by Services (Clinical Trials, Diagnostic Research, Drug Development Consultancy), Indication (Cardio Vascular Disorders, CNS Disorders, Diabetes), End-User, Deployment - Global Forecast 2024-2030
... USD 57.31 billion in 2023 and expected to reach USD 62.69 billion in 2024, at a CAGR 9.47% to reach USD 108.02 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Neurology Endoscopy Devices Market by Product (Accessories, Endoscopes, Operative Devices), Indication (Alzheimer’s Disorders, Brain Cancer, Brain Tumor), Usability, End User, Application - Global Forecast 2024-2030
... 5.19 billion in 2023 and expected to reach USD 5.56 billion in 2024, at a CAGR 7.22% to reach USD 8.46 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Transcatheter Devices Market by Product (Transcatheter Embolization & Occlusion Devices, Transcatheter Repair Devices, Transcatheter Replacement Devices), Application (Cardiovascular, Neurology, Oncology) - Global Forecast 2024-2030
... in 2023 and expected to reach USD 15.97 billion in 2024, at a CAGR 13.70% to reach USD 34.56 billion by 2030. Global Transcatheter Devices Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Antipsychotic Drugs Market by Class (First Generation, Second Generation, Third Generation), Indication (Bipolar Disorders, Dementia, Schizophrenia) - Global Forecast 2024-2030
... to reach USD 10.42 billion in 2024, at a CAGR 8.01% to reach USD 16.56 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Antipsychotic Drugs Market. It offers ... Read More
-
Neurology Patient Monitoring Market by Device (Cerebral Oximeters, Electroencephalography Monitors, Intracranial Pressure Monitors), Disease Type (Epilepsy, Parkinson's Disease, Sleep Disorders), End-User - Global Forecast 2024-2030
... 5.18 billion in 2023 and expected to reach USD 5.55 billion in 2024, at a CAGR 7.90% to reach USD 8.84 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Diaphragm Pacing Therapy System Market by Product (Diaphragm Pacemaker, External Diaphragm Pacemaker), Application (Amyotrophic Lateral Sclerosis, Spinal Cord Injury) - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 5.40 billion in 2024, at a CAGR 7.39% to reach USD 8.29 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Single Cell Sequencing Market by Product (Consumables, Instruments), Application (Immunology, Microbiology, Neurology), End-User - Global Forecast 2024-2030
... USD 2.64 billion in 2024, at a CAGR 4.87% to reach USD 3.51 billion by 2030. Global Single Cell Sequencing Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Single Cell ... Read More
-
Amyotrophic Lateral Sclerosis Treatment Market by Treatment (Medication, Stem Cell Therapy), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) - Global Forecast 2024-2030
... 2023 and expected to reach USD 790.52 million in 2024, at a CAGR 7.73% to reach USD 1,237.05 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Amyotrophic Lateral ... Read More
-
Interventional Neurology Devices Market by Type (Aneurysm Coiling & Embolization Devices, Cerebrospinal Fluid Management Devices, Neurothrombectomy Devices), End-User (Ambulatory Care Centers, Hospitals, Neurology Clinics) - Global Forecast 2024-2030
... estimated at USD 2.02 billion in 2023 and expected to reach USD 2.17 billion in 2024, at a CAGR 8.97% to reach USD 3.69 billion by 2030. Global Interventional Neurology Devices Market FPNV Positioning Matrix ... Read More
-
Neurology Devices Market by Product (Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurostimulation Devices), End User (Ambulatory Surgery Centers, Hospitals) - Global Forecast 2024-2030
... in 2023 and expected to reach USD 10.10 billion in 2024, at a CAGR 7.81% to reach USD 16.03 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Neurology ... Read More
-
Clinical Trial Patient Recruitment Services Market by Therapeutic Areas (Anti-Infective, Cardiovascular, Central Nervous System), Phase (Phase I, Phase II, Phase Ill), Age Group - Global Forecast 2024-2030
... was estimated at USD 1.16 billion in 2023 and expected to reach USD 1.27 billion in 2024, at a CAGR 9.63% to reach USD 2.22 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Brain Biomarkers Market by Product (Biomarker Analyzers, Biomarker Test Kits), Indication (Alzheimer's Disease, Huntington's Disease, MND & ALS), End-Users, Application - Global Forecast 2024-2030
... in 2023 and expected to reach USD 10.54 billion in 2024, at a CAGR 17.90% to reach USD 28.33 billion by 2030. Global Brain Biomarkers Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Brain Tumor Therapeutics Market by Type (Glioblastoma, Meningioma, Metastatic Brain Tumors), Therapy (Chemotherapy, Gene Therapy, Immunotherapy), Patient Age Group, Distribution Channel, End-User - Global Forecast 2024-2030
... USD 3.03 billion in 2023 and expected to reach USD 3.28 billion in 2024, at a CAGR 8.24% to reach USD 5.28 billion by 2030. Global Brain Tumor Therapeutics Market FPNV Positioning Matrix The FPNV ... Read More
-
Pediatric Imaging Market by Modality (Computed Tomography, Magnetic Resonance Imaging, Ultrasound), Application (Cardiology, Gastroenterology, Neurology), End-User - Global Forecast 2024-2030
... expected to reach USD 38.57 billion in 2024, at a CAGR 8.43% to reach USD 62.77 billion by 2030. Global Pediatric Medical Device Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Anxiety Drugs Market by Type (Generic Drugs, Patent Medicine), Application (Help Sleep, Treat Anxiety, Treat Premature Ejaculation) - Global Forecast 2024-2030
... expected to reach USD 19.03 billion in 2024, at a CAGR 8.78% to reach USD 31.56 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Anxiety Drugs Market. It ... Read More
-
Neuroprotection Market by Product (Apoptosis Inhibitors, Free Anti-Inflammatory Agents, Glutamate Antagonists), Treatment (Alzheimer's Disease, Amyotrophic Lateral Sclerosis, Brain Injury), Application - Global Forecast 2024-2030
... 2023 and expected to reach USD 16.20 billion in 2024, at a CAGR 9.86% to reach USD 28.52 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Neuroprotection Market. ... Read More
-
Behavioural Health Software Market Analysis and Forecast To 2033: By Component (Software, Services), Application (Clinical, Financial, Administrative), Delivery Model (Ownership Model, Subscription Model), Disorder Type (Anxiety, Post-Traumatic Stress Disorder (PSTD), Substance Abuse, Schizophrenia, Bipolar Disorders, And Others), End-Use (Hospitals, Community Clinics, Private Practices, Others), And Region
... And Others), End-Use (Hospitals, Community Clinics, Private Practices, Others), And Region The global behavioral health software market size was approximately USD 4.5 billion in 2023 and is expected to grow at a compound annual growth ... Read More
-
Dementia Associated with Alzheimer's Disease Market (Drug Class: Cholinergic/Cholinesterase Inhibitors, Memantine, Combined Drugs, Others; Distribution Channel: Hospital Pharmacies, Retail, Online Sales) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2023-2031
... Alzheimer's Disease Market – Scope of Report TMR’s report on the global dementia associated with Alzheimer’s disease market studies the past as well as the current growth trends and opportunities to gain valuable insights of ... Read More
-
Global Encephalitis Vaccine Market Research Report 2024(Status and Outlook)
... infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito’s classes. People and many animals may be infection source after infection Encephalitis virus. ... Read More
-
Global Tick-borne Encephalitis Inactivated Vaccine Market Research Report 2024(Status and Outlook)
... The major symptoms occurring as a result of TBE infection are headache, agitation, high temperature (fever), sickness (vomiting), and confusion. The Global Tick-borne Encephalitis Inactivated Vaccine Market Size was estimated at USD 562.57 million in ... Read More
-
Global Schizophrenia Treatments Market Research Report 2024(Status and Outlook)
... 8836.21 million in 2023 and is projected to reach USD 9834.51 million by 2029, exhibiting a CAGR of 1.80% during the forecast period. This report provides a deep insight into the global Schizophrenia Treatments market ... Read More
Research Assistance
